Freeman David W. 4
4 · QNB CORP. · Filed Feb 19, 2026
Research Summary
AI-generated summary of this filing
QNB Corp (QNBC) CEO David W. Freeman Receives Restricted Stock Awards
What Happened David W. Freeman, President and Chief Executive Officer of QNB Corp. (QNBC), was granted a total of 1,500 restricted shares on February 13, 2026. The awards consist of a 750-share restricted stock grant and three 250-share restricted/derivative awards, all reported at $38.00 per share. The combined value of the grants at grant price is $57,000 (750 shares = $28,500; three 250-share awards = $9,500 each, totaling $28,500).
Key Details
- Transaction date: 2026-02-13; reported on Form 4 filed 2026-02-19 (filed 6 days after the transaction; later than the typical 2-business-day Form 4 deadline).
- Price: $38.00 per share for all reported awards.
- Shares granted: 750 shares (direct restricted stock) + 3 × 250 shares (reported as derivative restricted awards) = 1,500 shares total.
- Reported value: ~$57,000 total at grant date price.
- Footnote: F1 — Restricted Stock Awards.
- Shares owned after transaction: Not disclosed in this filing.
Context These grants are compensation awards (restricted stock) rather than open-market purchases. Restricted awards typically vest over time or subject to conditions and are common executive pay; they do not necessarily indicate a personal cash purchase. The filing was submitted several days after the grant date, which is later than the usual 2-business-day reporting requirement for Form 4s.
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-13$38.00/sh+750$28,500→ 33,966.713 total - Award
Performance-based restricted stock award
2026-02-13$38.00/sh+250$9,500→ 250 totalExercise: $0.00From: 2026-02-13Exp: 2036-02-13→ Common Stock (250 underlying) - Award
Performance-based restricted stock award
2026-02-13$38.00/sh+250$9,500→ 250 totalExercise: $0.00From: 2027-02-13Exp: 2036-02-13→ Common Stock (250 underlying) - Award
Performance-based restricted stock award
2026-02-13$38.00/sh+250$9,500→ 250 totalExercise: $0.00From: 2028-02-13Exp: 2036-02-13→ Common Stock (250 underlying)
- 3,500
Common Stock(Right to Buy)
Exercise: $37.26From: 2025-02-15Exp: 2027-02-15→ Common Stock (3,500 underlying)
Footnotes (1)
- [F1]Restricted Stock Awards